Oxidative Stress Assays Market Size, Share & Trends Analysis By Product, By Test Type, By Technology, By Disease Type, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Global oxidative stress assays market is projected to be worth USD 1898 million by 2030
According to SPER Market Research, the oxidative stress assays market is estimated to reach USD 1898 million by 2030 with a CAGR of 8.6%. Rising prevalence of chronic and lifestyle disorders has led to the growth of biopharmaceutical and biotechnology companies which is further driving the growth of oxidative stress assays market.
Impact of COVID-19 on the Oxidative Stress Assays Market
COVID-19 has a slightly negative impact on oxidative stress assays market due to economic impact on companies, stringent regulatory process, disruptions in supply chain impacting the research activities. In upcoming years, academic research activities will rise leading to growth of oxidative stress assays market.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By Product, By Test Type, By Technology, By Disease, By End User
Geographies covered
North America, Europe, APAC, Latin America and the Middle East & Africa
Companies Covered
Abcam, plc, AMS Biotechnology, Arbor Assays, BioVision, Inc., Callegari SRL, Cayman Chemical, Cell Biolabs, Inc., Eagle Biosciences, Inc., Enzo Biochem, Inc., Genox Corporation, Hycult Biotech, ImmunoChemistry Technologies, LLC, Kamiya Biomedical Company, MEGA TIP San.Tic.Ltd.Sti., Merck KGaA, Oxford Biomedical Research, Promega Corporation, QIAGEN N.V., Thermo Fisher Scientific, Inc., Toxys B.V.
Driver: Rapidly growing biotechnology and biopharmaceutical industries
The biopharmaceutical and biotechnological industries are growing with technological advancements and rising demand. Oxidative stress assays are applied in both biopharmaceutical and biotechnological companies in cell cultures. Growth of these industries can drive the growth of oxidative stress assays market in the forecast period.
Restraints: Highly costly instruments
Advanced technologies for oxidative stress assays such as label-free detection and high-content screening are advantageous with advanced features and functions as compared to conventional technologies. Therefore, such instruments are priced at a premium cost. Companies with limited R&D budgets can not afford these instruments. The pharmaceutical companies require large number of such systems, thus overall cost of ownership combined with maintenance and indirect costs becomes very high. Thus, the cost of these instruments can restrain the growth of this market.
Opportunity: Growth opportunities in emerging economies
Emerging economies such as Russia, China, Brazil, India are offering growth opportunities to oxidative stress assays market. Factor attributing these opportunities is increasing R&D funding and investments for research organizations. Asian countries such as India and China have CROs that provide drug discovery services to pharmaceutical industries. The outsourcing of research work helps in increasing the efficiency in limited time.
Oxidative Stress Assays Market by Product:
Based on product, market has been segmented into Consumables, Kits, Reagents, Instruments, Services
Oxidative Stress Assays Market by Test Type:
Based on test type, the market is segmented into Antioxidant Capacity Assays, Ascorbic Acid Assays, Glutathione Assays, Cell-based Exogenous Antioxidant Assays, Indirect Assays, Lipid-based Assays, Nucleic Acid-based Assays, Protein-based Assays, Enzyme-based Assays, Reactive Oxygen Species-based Assays
Oxidative Stress Assays Market by Technology:
Based on technology, market has been segmented into Enzyme-linked Immunosorbent Assay (ELISA), Flow Cytometry, High-content Screening (HCS), Label-free Detection, Microscopy, Chromatography
Oxidative Stress Assays Market by Disease Type:
Based on disease type, market has been segmented into Cardiovascular Disease, Diabetes, Cancer, Respiratory Diseases, Other Diseases
Cardiovascular Disease segment accounted for largest share due to rising prevalence of cardiovascular diseases and unhealthy lifestyle.
Oxidative Stress Assays Market by End User:
Based on end user, the market is segmented into Clinical Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Cosmetic Companies
Oxidative Stress Assays Market by Region:
North America owns the largest share of this market owing to advanced healthcare infrastructure, rising investments in healthcare, presence of leading players and technological advancement. However, Asia Pacific will grow at the highest CAGR owing to supportive government initiatives, rising awareness, rising investments and rising income.
According to SPER Market Research, the oxidative stress assays market is estimated to reach USD 1898 million by 2030 with a CAGR of 8.6%. Rising prevalence of chronic and lifestyle disorders has led to the growth of biopharmaceutical and biotechnology companies which is further driving the growth of oxidative stress assays market.
Impact of COVID-19 on the Oxidative Stress Assays Market
COVID-19 has a slightly negative impact on oxidative stress assays market due to economic impact on companies, stringent regulatory process, disruptions in supply chain impacting the research activities. In upcoming years, academic research activities will rise leading to growth of oxidative stress assays market.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By Product, By Test Type, By Technology, By Disease, By End User
Geographies covered
North America, Europe, APAC, Latin America and the Middle East & Africa
Companies Covered
Abcam, plc, AMS Biotechnology, Arbor Assays, BioVision, Inc., Callegari SRL, Cayman Chemical, Cell Biolabs, Inc., Eagle Biosciences, Inc., Enzo Biochem, Inc., Genox Corporation, Hycult Biotech, ImmunoChemistry Technologies, LLC, Kamiya Biomedical Company, MEGA TIP San.Tic.Ltd.Sti., Merck KGaA, Oxford Biomedical Research, Promega Corporation, QIAGEN N.V., Thermo Fisher Scientific, Inc., Toxys B.V.
Driver: Rapidly growing biotechnology and biopharmaceutical industries
The biopharmaceutical and biotechnological industries are growing with technological advancements and rising demand. Oxidative stress assays are applied in both biopharmaceutical and biotechnological companies in cell cultures. Growth of these industries can drive the growth of oxidative stress assays market in the forecast period.
Restraints: Highly costly instruments
Advanced technologies for oxidative stress assays such as label-free detection and high-content screening are advantageous with advanced features and functions as compared to conventional technologies. Therefore, such instruments are priced at a premium cost. Companies with limited R&D budgets can not afford these instruments. The pharmaceutical companies require large number of such systems, thus overall cost of ownership combined with maintenance and indirect costs becomes very high. Thus, the cost of these instruments can restrain the growth of this market.
Opportunity: Growth opportunities in emerging economies
Emerging economies such as Russia, China, Brazil, India are offering growth opportunities to oxidative stress assays market. Factor attributing these opportunities is increasing R&D funding and investments for research organizations. Asian countries such as India and China have CROs that provide drug discovery services to pharmaceutical industries. The outsourcing of research work helps in increasing the efficiency in limited time.
Oxidative Stress Assays Market by Product:
Based on product, market has been segmented into Consumables, Kits, Reagents, Instruments, Services
Oxidative Stress Assays Market by Test Type:
Based on test type, the market is segmented into Antioxidant Capacity Assays, Ascorbic Acid Assays, Glutathione Assays, Cell-based Exogenous Antioxidant Assays, Indirect Assays, Lipid-based Assays, Nucleic Acid-based Assays, Protein-based Assays, Enzyme-based Assays, Reactive Oxygen Species-based Assays
Oxidative Stress Assays Market by Technology:
Based on technology, market has been segmented into Enzyme-linked Immunosorbent Assay (ELISA), Flow Cytometry, High-content Screening (HCS), Label-free Detection, Microscopy, Chromatography
Oxidative Stress Assays Market by Disease Type:
Based on disease type, market has been segmented into Cardiovascular Disease, Diabetes, Cancer, Respiratory Diseases, Other Diseases
Cardiovascular Disease segment accounted for largest share due to rising prevalence of cardiovascular diseases and unhealthy lifestyle.
Oxidative Stress Assays Market by End User:
Based on end user, the market is segmented into Clinical Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Cosmetic Companies
Oxidative Stress Assays Market by Region:
North America owns the largest share of this market owing to advanced healthcare infrastructure, rising investments in healthcare, presence of leading players and technological advancement. However, Asia Pacific will grow at the highest CAGR owing to supportive government initiatives, rising awareness, rising investments and rising income.
1. INTRODUCTION
1.1. Scope of the report
1.2. Market segment analysis
2. RESEARCH METHODOLOGY
2.1. Research data source
2.1.1. Secondary data
2.1.2. Primary data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impact of the Oxidative Stress Assays Market
5. MARKET VARIABLES AND OUTLOOK
5.1. SWOT analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL analysis
5.2.1. Political landscape
5.2.2. Economic landscape
5.2.3. Social landscape
5.2.4. Technological landscape
5.2.5. Environmental landscape
5.2.6. Legal landscape
5.3. PORTER’S five forces analysis
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of Buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat map analysis
6. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
6.1. Consumables
6.2. Kits
6.3. Reagents
6.4. Instruments
6.5. Services
7. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2019-2030 (USD MILLION)
7.1. Antioxidant Capacity Assays
7.2. Ascorbic Acid Assays
7.3. Glutathione Assays
7.4. Cell-based Exogenous Antioxidant Assays
7.5. Indirect Assays
7.6. Lipid-based Assays
7.7. Nucleic Acid-based Assays
7.8. Protein-based Assays
7.9. Enzyme-based Assays
7.10. Reactive Oxygen Species-based Assays
8. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
8.1. Enzyme-linked Immunosorbent Assay (ELISA)
8.2. Flow Cytometry
8.3. High-content Screening (HCS)
8.4. Label-free Detection
8.5. Microscopy
8.6. Chromatography
9. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2019-2030 (USD MILLION)
9.1. Cardiovascular Disease
9.2. Diabetes
9.3. Cancer
9.4. Respiratory Diseases
9.5. Other Diseases
10. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2019-2030 (USD MILLION)
10.1. Clinical Laboratories
10.2. Contract Research Organizations
10.3. Pharmaceutical and Biotechnology Companies
10.4. Academic Research Institutes
10.5. Cosmetic Companies
11. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY REGION, 2019-2030 (USD MILLION)
11.1. North America
11.1.1. United States
11.1.2. Canada
11.1.3. Mexico
11.2. Europe
11.2.1. Germany
11.2.2. United Kingdom
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. Japan
11.3.3. India
11.3.4. Australia
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. South America
11.4.1. Brazil
11.4.2. Argentina
11.4.3. Rest of South America
11.5. Middle East & Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Rest of Middle East & Africa
12. COMPANY PROFILES
12.1. Abcam, plc
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. AMS Biotechnology
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Arbor Assays
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. BioVision, Inc.
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Callegari SRL
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Cayman Chemical
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Cell Biolabs, Inc.
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Eagle Biosciences, Inc.
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Enzo Biochem, Inc.
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Genox Corporation
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Hycult Biotech
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
12.12. ImmunoChemistry Technologies, LLC
12.12.1. Company details
12.12.2. Financial outlook
12.12.3. Product summary
12.12.4. Recent developments
12.13. Kamiya Biomedical Company
12.13.1. Company details
12.13.2. Financial outlook
12.13.3. Product summary
12.13.4. Recent developments
12.14. MEGA TIP San.Tic.Ltd.Sti.
12.14.1. Company details
12.14.2. Financial outlook
12.14.3. Product summary
12.14.4. Recent developments
12.15. Merck KGaA
12.15.1. Company details
12.15.2. Financial outlook
12.15.3. Product summary
12.15.4. Recent developments
12.16. Oxford Biomedical Research
12.16.1. Company details
12.16.2. Financial outlook
12.16.3. Product summary
12.16.4. Recent developments
12.17. Promega Corporation
12.17.1. Company details
12.17.2. Financial outlook
12.17.3. Product summary
12.17.4. Recent developments
12.18. QIAGEN N.V.
12.18.1. Company details
12.18.2. Financial outlook
12.18.3. Product summary
12.18.4. Recent developments
12.19. Thermo Fisher Scientific, Inc.
12.19.1. Company details
12.19.2. Financial outlook
12.19.3. Product summary
12.19.4. Recent developments
12.20. Toxys B.V.
12.20.1. Company details
12.20.2. Financial outlook
12.20.3. Product summary
12.20.4. Recent developments
1.1. Scope of the report
1.2. Market segment analysis
2. RESEARCH METHODOLOGY
2.1. Research data source
2.1.1. Secondary data
2.1.2. Primary data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impact of the Oxidative Stress Assays Market
5. MARKET VARIABLES AND OUTLOOK
5.1. SWOT analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL analysis
5.2.1. Political landscape
5.2.2. Economic landscape
5.2.3. Social landscape
5.2.4. Technological landscape
5.2.5. Environmental landscape
5.2.6. Legal landscape
5.3. PORTER’S five forces analysis
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of Buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat map analysis
6. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
6.1. Consumables
6.2. Kits
6.3. Reagents
6.4. Instruments
6.5. Services
7. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE, 2019-2030 (USD MILLION)
7.1. Antioxidant Capacity Assays
7.2. Ascorbic Acid Assays
7.3. Glutathione Assays
7.4. Cell-based Exogenous Antioxidant Assays
7.5. Indirect Assays
7.6. Lipid-based Assays
7.7. Nucleic Acid-based Assays
7.8. Protein-based Assays
7.9. Enzyme-based Assays
7.10. Reactive Oxygen Species-based Assays
8. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
8.1. Enzyme-linked Immunosorbent Assay (ELISA)
8.2. Flow Cytometry
8.3. High-content Screening (HCS)
8.4. Label-free Detection
8.5. Microscopy
8.6. Chromatography
9. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2019-2030 (USD MILLION)
9.1. Cardiovascular Disease
9.2. Diabetes
9.3. Cancer
9.4. Respiratory Diseases
9.5. Other Diseases
10. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2019-2030 (USD MILLION)
10.1. Clinical Laboratories
10.2. Contract Research Organizations
10.3. Pharmaceutical and Biotechnology Companies
10.4. Academic Research Institutes
10.5. Cosmetic Companies
11. GLOBAL OXIDATIVE STRESS ASSAYS MARKET, BY REGION, 2019-2030 (USD MILLION)
11.1. North America
11.1.1. United States
11.1.2. Canada
11.1.3. Mexico
11.2. Europe
11.2.1. Germany
11.2.2. United Kingdom
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. Japan
11.3.3. India
11.3.4. Australia
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. South America
11.4.1. Brazil
11.4.2. Argentina
11.4.3. Rest of South America
11.5. Middle East & Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Rest of Middle East & Africa
12. COMPANY PROFILES
12.1. Abcam, plc
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. AMS Biotechnology
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Arbor Assays
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. BioVision, Inc.
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Callegari SRL
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Cayman Chemical
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Cell Biolabs, Inc.
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Eagle Biosciences, Inc.
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Enzo Biochem, Inc.
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Genox Corporation
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Hycult Biotech
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
12.12. ImmunoChemistry Technologies, LLC
12.12.1. Company details
12.12.2. Financial outlook
12.12.3. Product summary
12.12.4. Recent developments
12.13. Kamiya Biomedical Company
12.13.1. Company details
12.13.2. Financial outlook
12.13.3. Product summary
12.13.4. Recent developments
12.14. MEGA TIP San.Tic.Ltd.Sti.
12.14.1. Company details
12.14.2. Financial outlook
12.14.3. Product summary
12.14.4. Recent developments
12.15. Merck KGaA
12.15.1. Company details
12.15.2. Financial outlook
12.15.3. Product summary
12.15.4. Recent developments
12.16. Oxford Biomedical Research
12.16.1. Company details
12.16.2. Financial outlook
12.16.3. Product summary
12.16.4. Recent developments
12.17. Promega Corporation
12.17.1. Company details
12.17.2. Financial outlook
12.17.3. Product summary
12.17.4. Recent developments
12.18. QIAGEN N.V.
12.18.1. Company details
12.18.2. Financial outlook
12.18.3. Product summary
12.18.4. Recent developments
12.19. Thermo Fisher Scientific, Inc.
12.19.1. Company details
12.19.2. Financial outlook
12.19.3. Product summary
12.19.4. Recent developments
12.20. Toxys B.V.
12.20.1. Company details
12.20.2. Financial outlook
12.20.3. Product summary
12.20.4. Recent developments
